盘龙药业：第五届董事会第三次会议决议公告

Core Viewpoint - Panlong Pharmaceutical announced the approval of several proposals, including the conclusion of fundraising projects and the permanent allocation of surplus funds to supplement working capital [2] Group 1 - The third meeting of the fifth board of directors of Panlong Pharmaceutical was held [2] - The company approved the proposal regarding the conclusion of fundraising projects [2] - Surplus funds from the fundraising will be permanently allocated to enhance working capital [2]